nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2E1—Fingolimod—multiple sclerosis	0.164	0.332	CbGbCtD
Thioridazine—CYP2D6—Fingolimod—multiple sclerosis	0.078	0.158	CbGbCtD
Thioridazine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0769	0.156	CbGbCtD
Thioridazine—CYP2C19—Prednisone—multiple sclerosis	0.0401	0.0812	CbGbCtD
Thioridazine—CYP2E1—Dexamethasone—multiple sclerosis	0.0399	0.0809	CbGbCtD
Thioridazine—CYP2C8—Dexamethasone—multiple sclerosis	0.0298	0.0604	CbGbCtD
Thioridazine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0258	0.16	CbGeAlD
Thioridazine—CYP2C19—Dexamethasone—multiple sclerosis	0.025	0.0507	CbGbCtD
Thioridazine—CYP2C9—Dexamethasone—multiple sclerosis	0.0208	0.0421	CbGbCtD
Thioridazine—CYP2D6—Dexamethasone—multiple sclerosis	0.019	0.0385	CbGbCtD
Thioridazine—HTR7—pons—multiple sclerosis	0.00765	0.0474	CbGeAlD
Thioridazine—HTR2A—trigeminal nerve—multiple sclerosis	0.00678	0.042	CbGeAlD
Thioridazine—DRD1—nerve—multiple sclerosis	0.00635	0.0393	CbGeAlD
Thioridazine—HTR7—peripheral nervous system—multiple sclerosis	0.00509	0.0315	CbGeAlD
Thioridazine—HTR2A—pons—multiple sclerosis	0.00477	0.0296	CbGeAlD
Thioridazine—HTR7—nerve—multiple sclerosis	0.00397	0.0246	CbGeAlD
Thioridazine—DRD2—nerve—multiple sclerosis	0.00375	0.0232	CbGeAlD
Thioridazine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00373	0.0231	CbGeAlD
Thioridazine—HTR2A—pineal body—multiple sclerosis	0.00341	0.0211	CbGeAlD
Thioridazine—HTR2A—peripheral nervous system—multiple sclerosis	0.00318	0.0197	CbGeAlD
Thioridazine—DRD1—brainstem—multiple sclerosis	0.00273	0.0169	CbGeAlD
Thioridazine—HTR2A—nerve—multiple sclerosis	0.00248	0.0153	CbGeAlD
Thioridazine—HTR2C—brainstem—multiple sclerosis	0.00212	0.0131	CbGeAlD
Thioridazine—HTR6—nervous system—multiple sclerosis	0.00192	0.0119	CbGeAlD
Thioridazine—HTR6—central nervous system—multiple sclerosis	0.00185	0.0115	CbGeAlD
Thioridazine—HTR1A—brainstem—multiple sclerosis	0.00178	0.011	CbGeAlD
Thioridazine—DRD1—midbrain—multiple sclerosis	0.00174	0.0108	CbGeAlD
Thioridazine—HTR7—brainstem—multiple sclerosis	0.0017	0.0106	CbGeAlD
Thioridazine—Lethargy—Cladribine—multiple sclerosis	0.00169	0.0102	CcSEcCtD
Thioridazine—Vision blurred—Fingolimod—multiple sclerosis	0.00166	0.01	CcSEcCtD
Thioridazine—ADRA1A—brainstem—multiple sclerosis	0.00164	0.0102	CbGeAlD
Thioridazine—Menstruation irregular—Prednisone—multiple sclerosis	0.00162	0.00979	CcSEcCtD
Thioridazine—DRD2—brainstem—multiple sclerosis	0.00161	0.00998	CbGeAlD
Thioridazine—Leukopenia—Fingolimod—multiple sclerosis	0.00158	0.00955	CcSEcCtD
Thioridazine—DRD2—retina—multiple sclerosis	0.00155	0.00963	CbGeAlD
Thioridazine—ADRA1B—nervous system—multiple sclerosis	0.00153	0.00949	CbGeAlD
Thioridazine—HTR2C—medulla oblongata—multiple sclerosis	0.00148	0.00915	CbGeAlD
Thioridazine—ADRA1B—central nervous system—multiple sclerosis	0.00148	0.00914	CbGeAlD
Thioridazine—HTR6—brain—multiple sclerosis	0.00147	0.00909	CbGeAlD
Thioridazine—Sudden death—Methotrexate—multiple sclerosis	0.00146	0.00885	CcSEcCtD
Thioridazine—DRD1—nervous system—multiple sclerosis	0.00143	0.00885	CbGeAlD
Thioridazine—Eosinophilia—Cladribine—multiple sclerosis	0.00142	0.00859	CcSEcCtD
Thioridazine—Sweating increased—Cladribine—multiple sclerosis	0.0014	0.00845	CcSEcCtD
Thioridazine—DRD1—central nervous system—multiple sclerosis	0.00138	0.00852	CbGeAlD
Thioridazine—Pancytopenia—Cladribine—multiple sclerosis	0.00136	0.00824	CcSEcCtD
Thioridazine—HTR2C—midbrain—multiple sclerosis	0.00135	0.00836	CbGeAlD
Thioridazine—Hypotension—Fingolimod—multiple sclerosis	0.00135	0.00813	CcSEcCtD
Thioridazine—HTR2C—spinal cord—multiple sclerosis	0.00132	0.00816	CbGeAlD
Thioridazine—Amenorrhoea—Methylprednisolone—multiple sclerosis	0.00129	0.00779	CcSEcCtD
Thioridazine—Eruption—Methotrexate—multiple sclerosis	0.00122	0.00736	CcSEcCtD
Thioridazine—HTR7—medulla oblongata—multiple sclerosis	0.00119	0.00736	CbGeAlD
Thioridazine—Amenorrhoea—Dexamethasone—multiple sclerosis	0.00117	0.00708	CcSEcCtD
Thioridazine—Amenorrhoea—Betamethasone—multiple sclerosis	0.00117	0.00708	CcSEcCtD
Thioridazine—ADRA1B—brain—multiple sclerosis	0.00117	0.00726	CbGeAlD
Thioridazine—CHRM2—nervous system—multiple sclerosis	0.00115	0.00713	CbGeAlD
Thioridazine—HTR1A—midbrain—multiple sclerosis	0.00114	0.00704	CbGeAlD
Thioridazine—Oedema peripheral—Cladribine—multiple sclerosis	0.00113	0.00684	CcSEcCtD
Thioridazine—Dermatitis contact—Triamcinolone—multiple sclerosis	0.00112	0.00678	CcSEcCtD
Thioridazine—HTR2C—nervous system—multiple sclerosis	0.00111	0.00687	CbGeAlD
Thioridazine—HTR1A—spinal cord—multiple sclerosis	0.00111	0.00687	CbGeAlD
Thioridazine—CHRM2—central nervous system—multiple sclerosis	0.00111	0.00687	CbGeAlD
Thioridazine—Pancytopenia—Azathioprine—multiple sclerosis	0.00111	0.0067	CcSEcCtD
Thioridazine—KCNH2—medulla oblongata—multiple sclerosis	0.00111	0.00686	CbGeAlD
Thioridazine—DRD1—brain—multiple sclerosis	0.00109	0.00676	CbGeAlD
Thioridazine—HTR7—midbrain—multiple sclerosis	0.00109	0.00673	CbGeAlD
Thioridazine—HTR2C—central nervous system—multiple sclerosis	0.00107	0.00662	CbGeAlD
Thioridazine—HTR2A—brainstem—multiple sclerosis	0.00106	0.00658	CbGeAlD
Thioridazine—HTR7—spinal cord—multiple sclerosis	0.00106	0.00656	CbGeAlD
Thioridazine—DRD2—midbrain—multiple sclerosis	0.00103	0.00636	CbGeAlD
Thioridazine—Arrhythmia—Cladribine—multiple sclerosis	0.00103	0.0062	CcSEcCtD
Thioridazine—HTR2A—retina—multiple sclerosis	0.00103	0.00635	CbGeAlD
Thioridazine—Amenorrhoea—Prednisone—multiple sclerosis	0.00102	0.00617	CcSEcCtD
Thioridazine—Dermatitis contact—Dexamethasone—multiple sclerosis	0.00102	0.00615	CcSEcCtD
Thioridazine—Dermatitis contact—Betamethasone—multiple sclerosis	0.00102	0.00615	CcSEcCtD
Thioridazine—KCNH2—midbrain—multiple sclerosis	0.00101	0.00627	CbGeAlD
Thioridazine—Mental disorder—Cladribine—multiple sclerosis	0.00101	0.00608	CcSEcCtD
Thioridazine—Erythema—Cladribine—multiple sclerosis	0.001	0.00604	CcSEcCtD
Thioridazine—KCNH2—spinal cord—multiple sclerosis	0.000987	0.00611	CbGeAlD
Thioridazine—Diarrhoea—Fingolimod—multiple sclerosis	0.000985	0.00595	CcSEcCtD
Thioridazine—Agranulocytosis—Azathioprine—multiple sclerosis	0.000971	0.00587	CcSEcCtD
Thioridazine—Hepatotoxicity—Methotrexate—multiple sclerosis	0.00097	0.00586	CcSEcCtD
Thioridazine—CYP2D6—brainstem—multiple sclerosis	0.000968	0.006	CbGeAlD
Thioridazine—HTR1A—nervous system—multiple sclerosis	0.000934	0.00579	CbGeAlD
Thioridazine—Anaemia—Cladribine—multiple sclerosis	0.000925	0.00559	CcSEcCtD
Thioridazine—Sweating increased—Mitoxantrone—multiple sclerosis	0.000919	0.00555	CcSEcCtD
Thioridazine—Headache—Fingolimod—multiple sclerosis	0.000902	0.00545	CcSEcCtD
Thioridazine—HTR1A—central nervous system—multiple sclerosis	0.000899	0.00557	CbGeAlD
Thioridazine—Pancytopenia—Mitoxantrone—multiple sclerosis	0.000896	0.00542	CcSEcCtD
Thioridazine—HTR7—nervous system—multiple sclerosis	0.000893	0.00553	CbGeAlD
Thioridazine—CHRM2—brain—multiple sclerosis	0.00088	0.00545	CbGeAlD
Thioridazine—HTR1A—cerebellum—multiple sclerosis	0.000879	0.00545	CbGeAlD
Thioridazine—ADRA2A—medulla oblongata—multiple sclerosis	0.000871	0.0054	CbGeAlD
Thioridazine—ADRA1A—nervous system—multiple sclerosis	0.000861	0.00533	CbGeAlD
Thioridazine—HTR7—central nervous system—multiple sclerosis	0.00086	0.00532	CbGeAlD
Thioridazine—Weight increased—Mitoxantrone—multiple sclerosis	0.000859	0.00519	CcSEcCtD
Thioridazine—CYP2E1—medulla oblongata—multiple sclerosis	0.000852	0.00528	CbGeAlD
Thioridazine—Cardiac arrest—Prednisolone—multiple sclerosis	0.000852	0.00515	CcSEcCtD
Thioridazine—HTR2C—brain—multiple sclerosis	0.000848	0.00525	CbGeAlD
Thioridazine—DRD2—nervous system—multiple sclerosis	0.000844	0.00523	CbGeAlD
Thioridazine—Drowsiness—Mitoxantrone—multiple sclerosis	0.000841	0.00508	CcSEcCtD
Thioridazine—HTR7—cerebellum—multiple sclerosis	0.00084	0.0052	CbGeAlD
Thioridazine—Arrhythmia—Azathioprine—multiple sclerosis	0.000835	0.00504	CcSEcCtD
Thioridazine—KCNH2—nervous system—multiple sclerosis	0.000832	0.00515	CbGeAlD
Thioridazine—ADRA1A—central nervous system—multiple sclerosis	0.000829	0.00514	CbGeAlD
Thioridazine—Confusional state—Cladribine—multiple sclerosis	0.000823	0.00497	CcSEcCtD
Thioridazine—Jaundice—Mitoxantrone—multiple sclerosis	0.00082	0.00496	CcSEcCtD
Thioridazine—Oedema—Cladribine—multiple sclerosis	0.000816	0.00493	CcSEcCtD
Thioridazine—DRD2—central nervous system—multiple sclerosis	0.000813	0.00503	CbGeAlD
Thioridazine—ADRA1A—cerebellum—multiple sclerosis	0.00081	0.00502	CbGeAlD
Thioridazine—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.000803	0.00485	CcSEcCtD
Thioridazine—KCNH2—central nervous system—multiple sclerosis	0.000801	0.00496	CbGeAlD
Thioridazine—Thrombocytopenia—Cladribine—multiple sclerosis	0.000799	0.00483	CcSEcCtD
Thioridazine—Tachycardia—Cladribine—multiple sclerosis	0.000797	0.00481	CcSEcCtD
Thioridazine—ADRA2A—midbrain—multiple sclerosis	0.000796	0.00493	CbGeAlD
Thioridazine—DRD2—cerebellum—multiple sclerosis	0.000794	0.00492	CbGeAlD
Thioridazine—Hyperhidrosis—Cladribine—multiple sclerosis	0.000789	0.00477	CcSEcCtD
Thioridazine—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000785	0.00474	CcSEcCtD
Thioridazine—Cardiac arrest—Triamcinolone—multiple sclerosis	0.000783	0.00473	CcSEcCtD
Thioridazine—KCNH2—cerebellum—multiple sclerosis	0.000783	0.00485	CbGeAlD
Thioridazine—Hyperkinesia—Prednisone—multiple sclerosis	0.000782	0.00473	CcSEcCtD
Thioridazine—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.000781	0.00472	CcSEcCtD
Thioridazine—Anorexia—Cladribine—multiple sclerosis	0.000778	0.0047	CcSEcCtD
Thioridazine—ADRA2A—spinal cord—multiple sclerosis	0.000777	0.00481	CbGeAlD
Thioridazine—Ethopropazine—BCHE—multiple sclerosis	0.000776	0.261	CrCbGaD
Thioridazine—Hypotension—Cladribine—multiple sclerosis	0.000763	0.00461	CcSEcCtD
Thioridazine—Lethargy—Betamethasone—multiple sclerosis	0.000763	0.00461	CcSEcCtD
Thioridazine—Lethargy—Dexamethasone—multiple sclerosis	0.000763	0.00461	CcSEcCtD
Thioridazine—CYP2E1—spinal cord—multiple sclerosis	0.00076	0.00471	CbGeAlD
Thioridazine—Sweating increased—Prednisolone—multiple sclerosis	0.000754	0.00456	CcSEcCtD
Thioridazine—Anaemia—Azathioprine—multiple sclerosis	0.000752	0.00454	CcSEcCtD
Thioridazine—HTR2A—medulla oblongata—multiple sclerosis	0.000741	0.00459	CbGeAlD
Thioridazine—Psychotic disorder—Betamethasone—multiple sclerosis	0.00073	0.00441	CcSEcCtD
Thioridazine—Psychotic disorder—Dexamethasone—multiple sclerosis	0.00073	0.00441	CcSEcCtD
Thioridazine—Leukopenia—Azathioprine—multiple sclerosis	0.000728	0.0044	CcSEcCtD
Thioridazine—Somnolence—Cladribine—multiple sclerosis	0.000726	0.00439	CcSEcCtD
Thioridazine—HTR1A—brain—multiple sclerosis	0.000714	0.00442	CbGeAlD
Thioridazine—Asthma—Triamcinolone—multiple sclerosis	0.000712	0.0043	CcSEcCtD
Thioridazine—Cardiac arrest—Dexamethasone—multiple sclerosis	0.000711	0.00429	CcSEcCtD
Thioridazine—Cardiac arrest—Betamethasone—multiple sclerosis	0.000711	0.00429	CcSEcCtD
Thioridazine—Decreased appetite—Cladribine—multiple sclerosis	0.00071	0.00429	CcSEcCtD
Thioridazine—Weight increased—Prednisolone—multiple sclerosis	0.000705	0.00426	CcSEcCtD
Thioridazine—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000704	0.00425	CcSEcCtD
Thioridazine—Constipation—Cladribine—multiple sclerosis	0.000698	0.00422	CcSEcCtD
Thioridazine—Sweating increased—Triamcinolone—multiple sclerosis	0.000693	0.00419	CcSEcCtD
Thioridazine—Sweating increased—Methylprednisolone—multiple sclerosis	0.000692	0.00418	CcSEcCtD
Thioridazine—HTR7—brain—multiple sclerosis	0.000682	0.00423	CbGeAlD
Thioridazine—HTR2A—midbrain—multiple sclerosis	0.000677	0.00419	CbGeAlD
Thioridazine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000675	0.00408	CcSEcCtD
Thioridazine—Feeling abnormal—Cladribine—multiple sclerosis	0.000673	0.00407	CcSEcCtD
Thioridazine—Gynaecomastia—Methotrexate—multiple sclerosis	0.00067	0.00405	CcSEcCtD
Thioridazine—HRH1—nervous system—multiple sclerosis	0.000667	0.00413	CbGeAlD
Thioridazine—Lethargy—Prednisone—multiple sclerosis	0.000664	0.00401	CcSEcCtD
Thioridazine—HTR2A—spinal cord—multiple sclerosis	0.000661	0.00409	CbGeAlD
Thioridazine—ADRA1A—brain—multiple sclerosis	0.000658	0.00408	CbGeAlD
Thioridazine—Erythema—Mitoxantrone—multiple sclerosis	0.000657	0.00397	CcSEcCtD
Thioridazine—ADRA2A—nervous system—multiple sclerosis	0.000655	0.00406	CbGeAlD
Thioridazine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00065	0.00393	CcSEcCtD
Thioridazine—Weight increased—Triamcinolone—multiple sclerosis	0.000648	0.00392	CcSEcCtD
Thioridazine—Weight increased—Methylprednisolone—multiple sclerosis	0.000646	0.00391	CcSEcCtD
Thioridazine—Body temperature increased—Cladribine—multiple sclerosis	0.000645	0.0039	CcSEcCtD
Thioridazine—DRD2—brain—multiple sclerosis	0.000645	0.004	CbGeAlD
Thioridazine—HRH1—central nervous system—multiple sclerosis	0.000642	0.00398	CbGeAlD
Thioridazine—CYP2E1—nervous system—multiple sclerosis	0.000641	0.00397	CbGeAlD
Thioridazine—KCNH2—brain—multiple sclerosis	0.000636	0.00394	CbGeAlD
Thioridazine—Psychotic disorder—Prednisone—multiple sclerosis	0.000636	0.00384	CcSEcCtD
Thioridazine—Triflupromazine—BCHE—multiple sclerosis	0.000636	0.214	CrCbGaD
Thioridazine—ADRA2A—central nervous system—multiple sclerosis	0.00063	0.0039	CbGeAlD
Thioridazine—Sweating increased—Dexamethasone—multiple sclerosis	0.000629	0.0038	CcSEcCtD
Thioridazine—Sweating increased—Betamethasone—multiple sclerosis	0.000629	0.0038	CcSEcCtD
Thioridazine—Hypotension—Azathioprine—multiple sclerosis	0.00062	0.00375	CcSEcCtD
Thioridazine—Vision blurred—Mitoxantrone—multiple sclerosis	0.00062	0.00374	CcSEcCtD
Thioridazine—Photosensitivity—Methotrexate—multiple sclerosis	0.000619	0.00374	CcSEcCtD
Thioridazine—Cardiac arrest—Prednisone—multiple sclerosis	0.000619	0.00374	CcSEcCtD
Thioridazine—CYP2E1—central nervous system—multiple sclerosis	0.000617	0.00382	CbGeAlD
Thioridazine—ADRA2A—cerebellum—multiple sclerosis	0.000616	0.00382	CbGeAlD
Thioridazine—Anaemia—Mitoxantrone—multiple sclerosis	0.000608	0.00367	CcSEcCtD
Thioridazine—CYP2E1—cerebellum—multiple sclerosis	0.000603	0.00373	CbGeAlD
Thioridazine—Hypersensitivity—Cladribine—multiple sclerosis	0.000601	0.00363	CcSEcCtD
Thioridazine—Leukopenia—Mitoxantrone—multiple sclerosis	0.000589	0.00356	CcSEcCtD
Thioridazine—Weight increased—Dexamethasone—multiple sclerosis	0.000588	0.00355	CcSEcCtD
Thioridazine—Weight increased—Betamethasone—multiple sclerosis	0.000588	0.00355	CcSEcCtD
Thioridazine—CYP2C8—brain—multiple sclerosis	0.000582	0.0036	CbGeAlD
Thioridazine—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000576	0.00348	CcSEcCtD
Thioridazine—Diarrhoea—Cladribine—multiple sclerosis	0.000559	0.00338	CcSEcCtD
Thioridazine—HTR2A—nervous system—multiple sclerosis	0.000557	0.00345	CbGeAlD
Thioridazine—Lethargy—Methotrexate—multiple sclerosis	0.000555	0.00335	CcSEcCtD
Thioridazine—Arrhythmia—Prednisolone—multiple sclerosis	0.000554	0.00335	CcSEcCtD
Thioridazine—Sweating increased—Prednisone—multiple sclerosis	0.000548	0.00331	CcSEcCtD
Thioridazine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000547	0.00331	CcSEcCtD
Thioridazine—Confusional state—Mitoxantrone—multiple sclerosis	0.000541	0.00327	CcSEcCtD
Thioridazine—Erythema—Prednisolone—multiple sclerosis	0.000539	0.00326	CcSEcCtD
Thioridazine—Oedema—Mitoxantrone—multiple sclerosis	0.000537	0.00324	CcSEcCtD
Thioridazine—HTR2A—central nervous system—multiple sclerosis	0.000536	0.00332	CbGeAlD
Thioridazine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000525	0.00317	CcSEcCtD
Thioridazine—Body temperature increased—Azathioprine—multiple sclerosis	0.000525	0.00317	CcSEcCtD
Thioridazine—HTR2A—cerebellum—multiple sclerosis	0.000524	0.00325	CbGeAlD
Thioridazine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000524	0.00316	CcSEcCtD
Thioridazine—Vomiting—Cladribine—multiple sclerosis	0.000519	0.00314	CcSEcCtD
Thioridazine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000519	0.00313	CcSEcCtD
Thioridazine—Rash—Cladribine—multiple sclerosis	0.000515	0.00311	CcSEcCtD
Thioridazine—Dermatitis—Cladribine—multiple sclerosis	0.000514	0.00311	CcSEcCtD
Thioridazine—Weight increased—Prednisone—multiple sclerosis	0.000512	0.00309	CcSEcCtD
Thioridazine—Anorexia—Mitoxantrone—multiple sclerosis	0.000511	0.00309	CcSEcCtD
Thioridazine—Headache—Cladribine—multiple sclerosis	0.000511	0.00309	CcSEcCtD
Thioridazine—HRH1—brain—multiple sclerosis	0.00051	0.00316	CbGeAlD
Thioridazine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000509	0.00308	CcSEcCtD
Thioridazine—Vision blurred—Prednisolone—multiple sclerosis	0.000508	0.00307	CcSEcCtD
Thioridazine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000508	0.00307	CcSEcCtD
Thioridazine—CYP2D6—nervous system—multiple sclerosis	0.000507	0.00314	CbGeAlD
Thioridazine—Hypotension—Mitoxantrone—multiple sclerosis	0.000501	0.00303	CcSEcCtD
Thioridazine—ADRA2A—brain—multiple sclerosis	0.0005	0.0031	CbGeAlD
Thioridazine—Mental disorder—Methylprednisolone—multiple sclerosis	0.000498	0.00301	CcSEcCtD
Thioridazine—Erythema—Triamcinolone—multiple sclerosis	0.000496	0.003	CcSEcCtD
Thioridazine—Erythema—Methylprednisolone—multiple sclerosis	0.000495	0.00299	CcSEcCtD
Thioridazine—Angioedema—Prednisolone—multiple sclerosis	0.000493	0.00298	CcSEcCtD
Thioridazine—CYP2E1—brain—multiple sclerosis	0.00049	0.00303	CbGeAlD
Thioridazine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000489	0.00296	CcSEcCtD
Thioridazine—CYP2D6—central nervous system—multiple sclerosis	0.000488	0.00302	CbGeAlD
Thioridazine—Nausea—Cladribine—multiple sclerosis	0.000485	0.00293	CcSEcCtD
Thioridazine—CYP2D6—cerebellum—multiple sclerosis	0.000477	0.00296	CbGeAlD
Thioridazine—Somnolence—Mitoxantrone—multiple sclerosis	0.000477	0.00288	CcSEcCtD
Thioridazine—Asthma—Methotrexate—multiple sclerosis	0.00047	0.00284	CcSEcCtD
Thioridazine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000466	0.00282	CcSEcCtD
Thioridazine—Eosinophilia—Methotrexate—multiple sclerosis	0.000465	0.00281	CcSEcCtD
Thioridazine—Arrhythmia—Betamethasone—multiple sclerosis	0.000462	0.00279	CcSEcCtD
Thioridazine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000462	0.00279	CcSEcCtD
Thioridazine—Constipation—Mitoxantrone—multiple sclerosis	0.000459	0.00277	CcSEcCtD
Thioridazine—Diarrhoea—Azathioprine—multiple sclerosis	0.000454	0.00274	CcSEcCtD
Thioridazine—Angioedema—Triamcinolone—multiple sclerosis	0.000453	0.00274	CcSEcCtD
Thioridazine—Angioedema—Methylprednisolone—multiple sclerosis	0.000452	0.00273	CcSEcCtD
Thioridazine—Erythema—Betamethasone—multiple sclerosis	0.00045	0.00272	CcSEcCtD
Thioridazine—Erythema—Dexamethasone—multiple sclerosis	0.00045	0.00272	CcSEcCtD
Thioridazine—Pancytopenia—Methotrexate—multiple sclerosis	0.000446	0.0027	CcSEcCtD
Thioridazine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000442	0.00267	CcSEcCtD
Thioridazine—Oedema—Prednisolone—multiple sclerosis	0.00044	0.00266	CcSEcCtD
Thioridazine—Tachycardia—Prednisolone—multiple sclerosis	0.00043	0.0026	CcSEcCtD
Thioridazine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000429	0.00259	CcSEcCtD
Thioridazine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000426	0.00257	CcSEcCtD
Thioridazine—HTR2A—brain—multiple sclerosis	0.000426	0.00264	CbGeAlD
Thioridazine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000424	0.00256	CcSEcCtD
Thioridazine—Vomiting—Azathioprine—multiple sclerosis	0.000422	0.00255	CcSEcCtD
Thioridazine—Drowsiness—Methotrexate—multiple sclerosis	0.000419	0.00253	CcSEcCtD
Thioridazine—Rash—Azathioprine—multiple sclerosis	0.000419	0.00253	CcSEcCtD
Thioridazine—Dermatitis—Azathioprine—multiple sclerosis	0.000418	0.00253	CcSEcCtD
Thioridazine—Headache—Azathioprine—multiple sclerosis	0.000416	0.00251	CcSEcCtD
Thioridazine—Angioedema—Dexamethasone—multiple sclerosis	0.000411	0.00249	CcSEcCtD
Thioridazine—Angioedema—Betamethasone—multiple sclerosis	0.000411	0.00249	CcSEcCtD
Thioridazine—Confusional state—Methylprednisolone—multiple sclerosis	0.000407	0.00246	CcSEcCtD
Thioridazine—Oedema—Triamcinolone—multiple sclerosis	0.000405	0.00245	CcSEcCtD
Thioridazine—Arrhythmia—Prednisone—multiple sclerosis	0.000402	0.00243	CcSEcCtD
Thioridazine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000395	0.00239	CcSEcCtD
Thioridazine—Tachycardia—Triamcinolone—multiple sclerosis	0.000395	0.00239	CcSEcCtD
Thioridazine—Mental disorder—Prednisone—multiple sclerosis	0.000394	0.00238	CcSEcCtD
Thioridazine—Nausea—Azathioprine—multiple sclerosis	0.000394	0.00238	CcSEcCtD
Thioridazine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000394	0.00238	CcSEcCtD
Thioridazine—Erythema—Prednisone—multiple sclerosis	0.000392	0.00237	CcSEcCtD
Thioridazine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000391	0.00237	CcSEcCtD
Thioridazine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000391	0.00236	CcSEcCtD
Thioridazine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000391	0.00236	CcSEcCtD
Thioridazine—CYP2D6—brain—multiple sclerosis	0.000388	0.0024	CbGeAlD
Thioridazine—Hypotension—Methylprednisolone—multiple sclerosis	0.000377	0.00228	CcSEcCtD
Thioridazine—Vision blurred—Prednisone—multiple sclerosis	0.000369	0.00223	CcSEcCtD
Thioridazine—Oedema—Dexamethasone—multiple sclerosis	0.000367	0.00222	CcSEcCtD
Thioridazine—Oedema—Betamethasone—multiple sclerosis	0.000367	0.00222	CcSEcCtD
Thioridazine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000367	0.00222	CcSEcCtD
Thioridazine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000363	0.00219	CcSEcCtD
Thioridazine—Anaemia—Prednisone—multiple sclerosis	0.000362	0.00219	CcSEcCtD
Thioridazine—Agitation—Prednisone—multiple sclerosis	0.00036	0.00218	CcSEcCtD
Thioridazine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00036	0.00217	CcSEcCtD
Thioridazine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00036	0.00217	CcSEcCtD
Thioridazine—Tachycardia—Dexamethasone—multiple sclerosis	0.000359	0.00217	CcSEcCtD
Thioridazine—Tachycardia—Betamethasone—multiple sclerosis	0.000359	0.00217	CcSEcCtD
Thioridazine—Angioedema—Prednisone—multiple sclerosis	0.000358	0.00216	CcSEcCtD
Thioridazine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000355	0.00215	CcSEcCtD
Thioridazine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000355	0.00215	CcSEcCtD
Thioridazine—Anorexia—Dexamethasone—multiple sclerosis	0.00035	0.00212	CcSEcCtD
Thioridazine—Anorexia—Betamethasone—multiple sclerosis	0.00035	0.00212	CcSEcCtD
Thioridazine—Hypotension—Betamethasone—multiple sclerosis	0.000343	0.00207	CcSEcCtD
Thioridazine—Hypotension—Dexamethasone—multiple sclerosis	0.000343	0.00207	CcSEcCtD
Thioridazine—Vomiting—Mitoxantrone—multiple sclerosis	0.000341	0.00206	CcSEcCtD
Thioridazine—Rash—Mitoxantrone—multiple sclerosis	0.000338	0.00204	CcSEcCtD
Thioridazine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000338	0.00204	CcSEcCtD
Thioridazine—Headache—Mitoxantrone—multiple sclerosis	0.000336	0.00203	CcSEcCtD
Thioridazine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000334	0.00202	CcSEcCtD
Thioridazine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000333	0.00201	CcSEcCtD
Thioridazine—Mental disorder—Methotrexate—multiple sclerosis	0.00033	0.00199	CcSEcCtD
Thioridazine—Erythema—Methotrexate—multiple sclerosis	0.000328	0.00198	CcSEcCtD
Thioridazine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000324	0.00196	CcSEcCtD
Thioridazine—Body temperature increased—Triamcinolone—multiple sclerosis	0.00032	0.00193	CcSEcCtD
Thioridazine—Oedema—Prednisone—multiple sclerosis	0.00032	0.00193	CcSEcCtD
Thioridazine—Decreased appetite—Betamethasone—multiple sclerosis	0.000319	0.00193	CcSEcCtD
Thioridazine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000319	0.00193	CcSEcCtD
Thioridazine—Nausea—Mitoxantrone—multiple sclerosis	0.000319	0.00193	CcSEcCtD
Thioridazine—Tachycardia—Prednisone—multiple sclerosis	0.000312	0.00189	CcSEcCtD
Thioridazine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000309	0.00187	CcSEcCtD
Thioridazine—Vision blurred—Methotrexate—multiple sclerosis	0.000309	0.00187	CcSEcCtD
Thioridazine—Chlorpromazine—BCHE—multiple sclerosis	0.000307	0.103	CrCbGaD
Thioridazine—Anorexia—Prednisone—multiple sclerosis	0.000305	0.00184	CcSEcCtD
Thioridazine—Anaemia—Methotrexate—multiple sclerosis	0.000303	0.00183	CcSEcCtD
Thioridazine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000303	0.00183	CcSEcCtD
Thioridazine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000303	0.00183	CcSEcCtD
Thioridazine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000298	0.0018	CcSEcCtD
Thioridazine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000298	0.0018	CcSEcCtD
Thioridazine—Leukopenia—Methotrexate—multiple sclerosis	0.000293	0.00177	CcSEcCtD
Thioridazine—Body temperature increased—Dexamethasone—multiple sclerosis	0.00029	0.00175	CcSEcCtD
Thioridazine—Body temperature increased—Betamethasone—multiple sclerosis	0.00029	0.00175	CcSEcCtD
Thioridazine—Decreased appetite—Prednisone—multiple sclerosis	0.000278	0.00168	CcSEcCtD
Thioridazine—Rash—Prednisolone—multiple sclerosis	0.000278	0.00168	CcSEcCtD
Thioridazine—Dermatitis—Prednisolone—multiple sclerosis	0.000277	0.00168	CcSEcCtD
Thioridazine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000276	0.00167	CcSEcCtD
Thioridazine—Headache—Prednisolone—multiple sclerosis	0.000276	0.00167	CcSEcCtD
Thioridazine—Constipation—Prednisone—multiple sclerosis	0.000274	0.00165	CcSEcCtD
Thioridazine—Confusional state—Methotrexate—multiple sclerosis	0.00027	0.00163	CcSEcCtD
Thioridazine—Feeling abnormal—Prednisone—multiple sclerosis	0.000264	0.00159	CcSEcCtD
Thioridazine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000262	0.00158	CcSEcCtD
Thioridazine—Nausea—Prednisolone—multiple sclerosis	0.000261	0.00158	CcSEcCtD
Thioridazine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000258	0.00156	CcSEcCtD
Thioridazine—Vomiting—Triamcinolone—multiple sclerosis	0.000257	0.00156	CcSEcCtD
Thioridazine—Vomiting—Methylprednisolone—multiple sclerosis	0.000257	0.00155	CcSEcCtD
Thioridazine—Rash—Triamcinolone—multiple sclerosis	0.000255	0.00154	CcSEcCtD
Thioridazine—Dermatitis—Triamcinolone—multiple sclerosis	0.000255	0.00154	CcSEcCtD
Thioridazine—Anorexia—Methotrexate—multiple sclerosis	0.000255	0.00154	CcSEcCtD
Thioridazine—Rash—Methylprednisolone—multiple sclerosis	0.000255	0.00154	CcSEcCtD
Thioridazine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000254	0.00154	CcSEcCtD
Thioridazine—Headache—Triamcinolone—multiple sclerosis	0.000254	0.00153	CcSEcCtD
Thioridazine—Headache—Methylprednisolone—multiple sclerosis	0.000253	0.00153	CcSEcCtD
Thioridazine—Body temperature increased—Prednisone—multiple sclerosis	0.000253	0.00153	CcSEcCtD
Thioridazine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000251	0.00152	CcSEcCtD
Thioridazine—Diarrhoea—Betamethasone—multiple sclerosis	0.000251	0.00152	CcSEcCtD
Thioridazine—Hypotension—Methotrexate—multiple sclerosis	0.00025	0.00151	CcSEcCtD
Thioridazine—Acepromazine—ALB—multiple sclerosis	0.000241	0.0813	CrCbGaD
Thioridazine—Nausea—Triamcinolone—multiple sclerosis	0.00024	0.00145	CcSEcCtD
Thioridazine—Nausea—Methylprednisolone—multiple sclerosis	0.00024	0.00145	CcSEcCtD
Thioridazine—Somnolence—Methotrexate—multiple sclerosis	0.000238	0.00144	CcSEcCtD
Thioridazine—Thioproperazine—ALB—multiple sclerosis	0.000236	0.0795	CrCbGaD
Thioridazine—Hypersensitivity—Prednisone—multiple sclerosis	0.000236	0.00142	CcSEcCtD
Thioridazine—Vomiting—Dexamethasone—multiple sclerosis	0.000234	0.00141	CcSEcCtD
Thioridazine—Vomiting—Betamethasone—multiple sclerosis	0.000234	0.00141	CcSEcCtD
Thioridazine—Decreased appetite—Methotrexate—multiple sclerosis	0.000232	0.0014	CcSEcCtD
Thioridazine—Thiothixene—ALB—multiple sclerosis	0.000232	0.0782	CrCbGaD
Thioridazine—Pipotiazine—ALB—multiple sclerosis	0.000232	0.0782	CrCbGaD
Thioridazine—Rash—Dexamethasone—multiple sclerosis	0.000232	0.0014	CcSEcCtD
Thioridazine—Rash—Betamethasone—multiple sclerosis	0.000232	0.0014	CcSEcCtD
Thioridazine—Dermatitis—Betamethasone—multiple sclerosis	0.000231	0.0014	CcSEcCtD
Thioridazine—Dermatitis—Dexamethasone—multiple sclerosis	0.000231	0.0014	CcSEcCtD
Thioridazine—Headache—Dexamethasone—multiple sclerosis	0.00023	0.00139	CcSEcCtD
Thioridazine—Headache—Betamethasone—multiple sclerosis	0.00023	0.00139	CcSEcCtD
Thioridazine—Feeling abnormal—Methotrexate—multiple sclerosis	0.00022	0.00133	CcSEcCtD
Thioridazine—Diarrhoea—Prednisone—multiple sclerosis	0.000219	0.00132	CcSEcCtD
Thioridazine—Nausea—Betamethasone—multiple sclerosis	0.000218	0.00132	CcSEcCtD
Thioridazine—Nausea—Dexamethasone—multiple sclerosis	0.000218	0.00132	CcSEcCtD
Thioridazine—Body temperature increased—Methotrexate—multiple sclerosis	0.000211	0.00128	CcSEcCtD
Thioridazine—Vomiting—Prednisone—multiple sclerosis	0.000203	0.00123	CcSEcCtD
Thioridazine—Rash—Prednisone—multiple sclerosis	0.000202	0.00122	CcSEcCtD
Thioridazine—Dermatitis—Prednisone—multiple sclerosis	0.000202	0.00122	CcSEcCtD
Thioridazine—Headache—Prednisone—multiple sclerosis	0.0002	0.00121	CcSEcCtD
Thioridazine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000197	0.00119	CcSEcCtD
Thioridazine—Nausea—Prednisone—multiple sclerosis	0.00019	0.00115	CcSEcCtD
Thioridazine—Clomipramine—ALB—multiple sclerosis	0.000184	0.0618	CrCbGaD
Thioridazine—Diarrhoea—Methotrexate—multiple sclerosis	0.000183	0.00111	CcSEcCtD
Thioridazine—Vomiting—Methotrexate—multiple sclerosis	0.00017	0.00103	CcSEcCtD
Thioridazine—Rash—Methotrexate—multiple sclerosis	0.000169	0.00102	CcSEcCtD
Thioridazine—Dermatitis—Methotrexate—multiple sclerosis	0.000168	0.00102	CcSEcCtD
Thioridazine—Headache—Methotrexate—multiple sclerosis	0.000167	0.00101	CcSEcCtD
Thioridazine—Nausea—Methotrexate—multiple sclerosis	0.000159	0.00096	CcSEcCtD
Thioridazine—Chlorpromazine—ALB—multiple sclerosis	0.000126	0.0424	CrCbGaD
Thioridazine—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	2.03e-05	0.000115	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	2.02e-05	0.000114	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	2.02e-05	0.000114	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	2.02e-05	0.000114	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	2.01e-05	0.000113	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	2e-05	0.000113	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	2e-05	0.000113	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	2e-05	0.000113	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—MAPK1—multiple sclerosis	1.99e-05	0.000113	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—MAPK1—multiple sclerosis	1.99e-05	0.000112	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.99e-05	0.000112	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	1.97e-05	0.000111	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	1.97e-05	0.000111	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	1.96e-05	0.000111	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	1.96e-05	0.000111	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CD86—multiple sclerosis	1.95e-05	0.00011	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	1.94e-05	0.00011	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	1.93e-05	0.000109	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	1.93e-05	0.000109	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	1.93e-05	0.000109	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	1.92e-05	0.000109	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CD86—multiple sclerosis	1.92e-05	0.000109	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	1.92e-05	0.000108	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CD86—multiple sclerosis	1.92e-05	0.000108	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.91e-05	0.000108	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	1.89e-05	0.000107	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	1.89e-05	0.000107	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CD80—multiple sclerosis	1.89e-05	0.000107	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	1.89e-05	0.000107	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	1.88e-05	0.000106	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	1.88e-05	0.000106	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	1.86e-05	0.000105	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	1.86e-05	0.000105	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	1.85e-05	0.000105	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	1.85e-05	0.000105	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TYK2—multiple sclerosis	1.85e-05	0.000105	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TYK2—multiple sclerosis	1.85e-05	0.000104	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	1.84e-05	0.000104	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	1.83e-05	0.000104	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	1.83e-05	0.000103	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.83e-05	0.000103	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.82e-05	0.000103	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.81e-05	0.000102	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	1.8e-05	0.000102	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.8e-05	0.000102	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.79e-05	0.000101	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—APOE—multiple sclerosis	1.79e-05	0.000101	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—POMC—multiple sclerosis	1.79e-05	0.000101	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1.78e-05	0.000101	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	1.78e-05	0.000101	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CCL2—multiple sclerosis	1.75e-05	9.91e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	1.75e-05	9.89e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.75e-05	9.87e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.75e-05	9.87e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	1.73e-05	9.78e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.72e-05	9.72e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	1.72e-05	9.71e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—MAPK1—multiple sclerosis	1.72e-05	9.69e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.71e-05	9.69e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	1.71e-05	9.65e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	1.71e-05	9.64e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	1.7e-05	9.62e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	1.7e-05	9.6e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	1.69e-05	9.57e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—APOE—multiple sclerosis	1.69e-05	9.53e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	1.68e-05	9.49e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.67e-05	9.47e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	1.67e-05	9.45e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.67e-05	9.43e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.67e-05	9.42e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	1.67e-05	9.41e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.66e-05	9.39e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	1.65e-05	9.31e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.64e-05	9.29e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.64e-05	9.25e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	1.64e-05	9.24e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.63e-05	9.22e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CD80—multiple sclerosis	1.62e-05	9.16e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.61e-05	9.12e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.59e-05	9e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TYK2—multiple sclerosis	1.59e-05	9e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.57e-05	8.9e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.55e-05	8.76e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.55e-05	8.76e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—APOE—multiple sclerosis	1.55e-05	8.75e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.55e-05	8.74e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.55e-05	8.74e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	1.54e-05	8.73e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	1.54e-05	8.71e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL2—multiple sclerosis	1.54e-05	8.7e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL2—multiple sclerosis	1.54e-05	8.69e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.53e-05	8.66e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—IL6—multiple sclerosis	1.53e-05	8.65e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—IL6—multiple sclerosis	1.53e-05	8.64e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.53e-05	8.63e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	1.52e-05	8.6e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.52e-05	8.57e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.52e-05	8.56e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	1.51e-05	8.52e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.5e-05	8.48e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.47e-05	8.34e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.47e-05	8.29e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	1.47e-05	8.29e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MMP9—multiple sclerosis	1.46e-05	8.23e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MMP9—multiple sclerosis	1.45e-05	8.22e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—POMC—multiple sclerosis	1.45e-05	8.18e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	1.44e-05	8.11e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.42e-05	8.05e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.41e-05	7.97e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	1.4e-05	7.94e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.4e-05	7.92e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.4e-05	7.9e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	1.38e-05	7.77e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.37e-05	7.75e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	1.37e-05	7.74e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.36e-05	7.7e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.35e-05	7.64e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—APOE—multiple sclerosis	1.34e-05	7.56e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.33e-05	7.52e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—POMC—multiple sclerosis	1.33e-05	7.52e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.33e-05	7.51e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL2—multiple sclerosis	1.32e-05	7.49e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.32e-05	7.48e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—ALB—multiple sclerosis	1.32e-05	7.46e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—IL6—multiple sclerosis	1.32e-05	7.45e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.31e-05	7.39e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	1.3e-05	7.37e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.3e-05	7.37e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.3e-05	7.36e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.3e-05	7.34e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.29e-05	7.32e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—STAT3—multiple sclerosis	1.29e-05	7.32e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—STAT3—multiple sclerosis	1.29e-05	7.31e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.28e-05	7.23e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	1.28e-05	7.21e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.27e-05	7.2e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.27e-05	7.2e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	1.27e-05	7.19e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MMP9—multiple sclerosis	1.25e-05	7.08e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.25e-05	7.07e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.25e-05	7.05e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ALB—multiple sclerosis	1.21e-05	6.85e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.21e-05	6.84e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MYC—multiple sclerosis	1.2e-05	6.8e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.2e-05	6.79e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MYC—multiple sclerosis	1.2e-05	6.79e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	1.2e-05	6.78e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	1.2e-05	6.78e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—APOE—multiple sclerosis	1.19e-05	6.75e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1.18e-05	6.7e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	1.18e-05	6.68e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	1.18e-05	6.67e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	1.18e-05	6.65e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	1.18e-05	6.64e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.16e-05	6.56e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.16e-05	6.55e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	1.16e-05	6.54e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—POMC—multiple sclerosis	1.15e-05	6.5e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	1.14e-05	6.44e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	1.13e-05	6.4e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	1.13e-05	6.4e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	1.13e-05	6.37e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—STAT3—multiple sclerosis	1.11e-05	6.3e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.1e-05	6.21e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—APOE—multiple sclerosis	1.09e-05	6.15e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	1.08e-05	6.13e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	1.08e-05	6.1e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	1.08e-05	6.09e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	1.08e-05	6.08e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	1.07e-05	6.06e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ALB—multiple sclerosis	1.05e-05	5.92e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MYC—multiple sclerosis	1.04e-05	5.85e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	1.03e-05	5.84e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	1.03e-05	5.8e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—POMC—multiple sclerosis	1.03e-05	5.8e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	1.01e-05	5.73e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL2—multiple sclerosis	1e-05	5.65e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	9.95e-06	5.62e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	9.84e-06	5.56e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2—multiple sclerosis	9.82e-06	5.55e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	9.79e-06	5.53e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	9.77e-06	5.52e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	9.66e-06	5.46e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	9.63e-06	5.45e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	9.61e-06	5.43e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	9.59e-06	5.42e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	9.58e-06	5.42e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	9.53e-06	5.39e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	9.46e-06	5.35e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—POMC—multiple sclerosis	9.44e-06	5.33e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—POMC—multiple sclerosis	9.35e-06	5.29e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ALB—multiple sclerosis	9.35e-06	5.29e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	9.31e-06	5.26e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOE—multiple sclerosis	9.31e-06	5.26e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	9.29e-06	5.25e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	9.14e-06	5.17e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	9.13e-06	5.16e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	9.12e-06	5.15e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—multiple sclerosis	9.04e-06	5.11e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—multiple sclerosis	9.03e-06	5.11e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	8.95e-06	5.06e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	8.91e-06	5.03e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	8.91e-06	5.03e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	8.88e-06	5.02e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	8.86e-06	5.01e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	8.84e-06	5e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	8.71e-06	4.92e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	8.67e-06	4.9e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ALB—multiple sclerosis	8.6e-06	4.86e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ALB—multiple sclerosis	8.53e-06	4.82e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	8.48e-06	4.79e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	8.47e-06	4.79e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	8.46e-06	4.78e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	8.41e-06	4.76e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	8.3e-06	4.69e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	8.28e-06	4.68e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	8.26e-06	4.67e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	8.13e-06	4.59e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	8.11e-06	4.58e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—POMC—multiple sclerosis	7.99e-06	4.52e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MYC—multiple sclerosis	7.82e-06	4.42e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	7.8e-06	4.41e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—multiple sclerosis	7.78e-06	4.4e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	7.69e-06	4.35e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MYC—multiple sclerosis	7.68e-06	4.34e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	7.67e-06	4.34e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	7.66e-06	4.33e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	7.65e-06	4.32e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	7.55e-06	4.27e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	7.54e-06	4.26e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	7.53e-06	4.26e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	7.53e-06	4.26e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	7.53e-06	4.25e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	7.51e-06	4.25e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	7.51e-06	4.24e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	7.39e-06	4.18e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	7.37e-06	4.17e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ALB—multiple sclerosis	7.29e-06	4.12e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	7e-06	3.96e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	6.98e-06	3.95e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	6.85e-06	3.87e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	6.69e-06	3.78e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	6.66e-06	3.76e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	6.38e-06	3.6e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—multiple sclerosis	5.88e-06	3.32e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	5.78e-06	3.27e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—multiple sclerosis	5.77e-06	3.26e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	5.68e-06	3.21e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	5.66e-06	3.2e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	5.26e-06	2.97e-05	CbGpPWpGaD
